*Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute
†UCSD Health Department of Biomedical Informatics, University of California San Diego, La Jolla, CA
‡Eindhoven University of Technology, The Netherlands
J.S.C. and S.L.B. contributed to this work equally.
Presented at ARVO, 5/2022.
This study was supported by the National Institutes of Health (Bethesda, MD, Grants T15LM01127, DP5OD029610, P30EY022589, EY026574, K99EY030942 R01EY027510, R01EY029058). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in the design or conduct of this research.
Disclosure: L.M.Z. is a consultant for Abbvie Inc. Digital Diagnostics, receives research funding from the National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc, Topcon Medical Systems Inc, and has patented intellectual property with Zeiss Meditec. R.N.W. is a consultant for Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Iantrek, Implandata, Nicox, Topcon Medical, and receives research funding from the National Eye Institute, National Institute on Minority Health and Health Disparities, Bausch & Lomb, Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue, and has patented intellectual property licensed by the University of California San Diego to Zeiss Meditec and Toromedes. The remaining authors declare no conflict of interest.
Reprints: Linda M. Zangwill, PhD, 9415 Campus Point Drive, MC 0946, La Jolla, CA 92093-0946 (e-mail: [email protected]).
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.glaucomajournal.com.
